Revenues double at pharma firm as it hails 'ground-breaking' clinical results
Chairman predicts "huge potential value" both for cancer patients and investors in the next period.
Source: thebusinessdesk.com
Avacta Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Avacta Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Avacta Life Sciences Today - Breaking & Trending Today
Scaffold Technology Market Share Predictions suggest a rise of 11.3% CAGR to reach value of USD 3.5 Billion by 2032
Scaffold Technology Market Share Predictions suggest a rise of 11.3% CAGR to reach value of USD 3.5 Billion by 2032
Source: itnewsonline.com
Reviewing POINT Biopharma Global (NASDAQ:PNT) and Cybin (OTCMKTS:CYBN)
POINT Biopharma Global (NASDAQ:PNT – Free Report) and Cybin (OTCMKTS:CYBN – Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, institutional ownership and risk. Valuation & Earnings This table compares POINT Biopharma Global […]
Source: theenterpriseleader.com
Avacta : Dr. Fiona McLaughlin BIO 2023 presentation
Transforming treatment outcomes for cancer patients BIO June 2023 Dr. Fiona McLaughlin, Chief Scientific Officer ... | June 10, 2023
Source: marketscreener.com
Scaffold Technology Market | Merck KGaA, Tecan Trading AG, REPROCELL Inc., 3D Biotek LLC | By 2032
According to a recently published Scaffold Technology industry analysis report by Future Market Insights, global Scaffold Technology Market sales in 2021 were estimated to be US$ 1 Bn. The market is anticipated to grow at a CAGR of 11.3% between 2022 and 2032, reaching a US$ 3.3 Bn valuation. The greatest revenue-ge...
Source: pharmiweb.com